investment

News

Former Pfizer chief executive and chair Ian Read (l) and former finance chief Frank D’Amelio (r)

Ex-Pfizer leaders side with firm against activist investor

Two former Pfizer executives drawn into a campaign by activist investor Starboard Value to shake up the company have withdrawn their support for the plan.

News

Activist investor Starboard builds $1bn Pfizer stake

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group Pfizer and wants strategic changes to restore growth.

R&D

LSX USA Jonah Comstock and Eloise McLennan Wrapup

Investment outlook: Key takeaways from LSX USA

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies.

Digital

From PDURS to D2C, Frontiers Health speaks to cutting edge h...

Premiere healthcare innovation event Frontiers Health is just under a month away.

News

Lilly ramps up Irish manufacturing investment by $1bn

Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.

Market Access

Overcoming regulatory hurdles to unleash breakthrough innova...

The life sciences industry is currently undergoing a significant transformation, driven by the rapid development of new modalities such as cell and gene therapies (CAGT), and substantial ne

Ex-Pfizer leaders side with firm against activist investor

Activist investor Starboard builds $1bn Pfizer stake

Investment outlook: Key takeaways from LSX USA

From PDURS to D2C, Frontiers Health speaks to cutting edge h...

Lilly ramps up Irish manufacturing investment by $1bn

Overcoming regulatory hurdles to unleash breakthrough innova...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

investment

Editor's Picks